BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7012667)

  • 1. Is there a non-dopaminergic nigrostriatal pathway?
    van der Kooy D; Coscina DV; Hattori T
    Neuroscience; 1981; 6(3):345-57. PubMed ID: 7012667
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective lesions of mesostriatal dopamine neurons ameliorate hypoglycemic damage in the caudate-putamen.
    Lindvall O; Auer RN; Siesjö BK
    Exp Brain Res; 1986; 63(2):382-6. PubMed ID: 3758254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methamphetamine on blood flow in the caudate-putamen after lesions of the nigrostriatal dopaminergic bundle in the rat.
    Lindvall O; Ingvar M; Stenevi U
    Brain Res; 1981 Apr; 211(1):211-6. PubMed ID: 7225839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
    Fuxe K; Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):41-7. PubMed ID: 817332
    [No Abstract]   [Full Text] [Related]  

  • 6. Transmitters for the afferent and efferent systems of the neostriatum and their possible interactions.
    Kim JS
    Adv Biochem Psychopharmacol; 1978; 19():217-33. PubMed ID: 29447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesions of the nigro-neostriatal dopamine neurons or the bulbo-spinal norepinephrine and 5-hydroxytryptamine neurons in rats: action of drugs.
    Andén NE
    Pharmacol Ther B; 1975; 1(3):371-80. PubMed ID: 772707
    [No Abstract]   [Full Text] [Related]  

  • 8. Striatal efferent fibers play a role in maintaining rotational behavior in the rat.
    Marshall JF; Ungerstedt U
    Science; 1977 Oct; 198(4312):62-4. PubMed ID: 897683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents.
    Campbell K; Wictorin K; Björklund A
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10489-93. PubMed ID: 1438238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine-induced changes in local cerebral blood flow in normal rats and after lesions of the dopaminergic nigrostriatal bundle.
    Ingvar M; Lindvall O; Stenevi U
    Brain Res; 1983 Mar; 262(2):259-65. PubMed ID: 6404503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic substrates of intracranial self-stimulation in the caudate-putamen.
    Phillips AG; Carter DA; Fibiger HC
    Brain Res; 1976 Mar; 104(2):221-32. PubMed ID: 1260420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the cholinergic and dopaminergic innervation of the neostriatum with the help of intraneostriatal injections of drugs.
    Fuxe K; Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):29-36. PubMed ID: 772720
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.
    Coirini H; Schumacher M; Angulo JA; McEwen BS
    Eur J Pharmacol; 1990 Sep; 186(2-3):369-71. PubMed ID: 2127022
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen.
    Costall B; Naylor RJ; Cannon JG; Lee T
    J Pharm Pharmacol; 1977 Jun; 29(6):337-42. PubMed ID: 18569
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic supersensitivity in the striatum.
    Ungerstedt U; Ljungberg T; Hoffer B; Siggins G
    Adv Neurol; 1975; 9():57-65. PubMed ID: 167568
    [No Abstract]   [Full Text] [Related]  

  • 17. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic nerve endings in the neostriatum of the rat--1. Identification by intracerebral injections of 5-hydroxydopamine.
    Arluison M; Agid Y; Javoy F
    Neuroscience; 1978; 3(8):657-73. PubMed ID: 714245
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional validation of projection topography in the nigrostriatal dopamine system.
    Redgrave P; Mitchell I
    Neuroscience; 1982 Apr; 7(4):885-94. PubMed ID: 6808415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Spontaneous activity of single units in the striatum after unilateral destruction of the dopamine input.
    Arbuthnott GW
    J Physiol; 1974 Jun; 239(2):121P-122P. PubMed ID: 4415288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.